Skip to main content
. 2017 Feb 9;8(10):17202–17215. doi: 10.18632/oncotarget.15231

Table 3. Subgroup analysis for association between EGFR expression and overall survival in GC patients.

Overall survival 95%CI Heterogeneity
Group factors Subgroup HR P value Lower Upper I 2 P value
Total Total 1.19 0.015 1.04 1.37 66.4% 0.001
Contain stage IV patients Yes 1.11 0.302 0.91 1.37 55.9% 0.059
No 1.22 0.052 1.0 1.5 65.4% 0.001
Chemistry therapy Yes 1.21 0.291 0.85 1.71 65.4% 0.008
No 1.18 0.042 1.01 1.38 65.8% 0.001
Patients number≥100 Yes 1.13 0.113 0.97 1.31 68.5% 0.001
No 1.44 0.044 1.01 2.05 48.3% 0.06
Positive rate≥50% Yes 1.04 0.744 0.84 1.28 54.7% 0.024
No 1.29 0.012 1.06 1.59 63.1% 0.001

HR, hazard ratio; CI, confidence interval.